Business
CANAQUEST PRESIDENT INTERVIEWED BY THE WALL STREET ANALYZER
CANAQUEST PRESIDENT INTERVIEWED BY THE WALL STREET ANALYZER.
About this update from Canaquest Medical Corporation
[{"type":"text","content":"\n TORONTO, Jan. 19, 2021 (GLOBE NEWSWIRE) -- CANAQUEST MEDICAL CORP (OTC Markets: “CANQF”) (the \"Company\" or “CanaQuest”), a Life Science/Pharmaceutical Company developing health products utilizing cannabinoid molecules and other botanical compounds (pharmaceutical grade), is pleased to release a recent interview with company Co-founder and President, Paul Ramsay, on The Wall Street Analyzer, a multi-media financial research and publishing company reporting to the investment community on publicly held companies. It can be heard in full at: https://wallstreetanalyzer.com/2020/12/23/canaquest-medical-corp-otc-canqf/ Highlights in the discussion include significant milestones achieved by the Company: The Announcement that The Journal of Neuroscience has published the findings of Western University’s research leading to the discovery of Mentabinol®, a patented THC based formulation & L-theanine - a safer alternative, for people who are taking THC for mental ailments, long-term pain, chemotherapy side-effects or reducing anxiety or depression. Mentabinol® could also be a viable treatment to help address and alleviate the opioid crisis. Second Master FormulationMentanine®, Omega-3 + CBD, non-psychotic - crosses the Blood Brain Barrier (BBB), CBD by itself, is not effective for mental health - does not cross the Blood Brain Barrier. Mentanine® has ~10x the efficacy of a CBD-based FDA-approved product by GW Pharma ($4B market cap) Looking to start clinical trials of Mentanine® as a treatment of epilepsy FDA-approval process expected to take 18 to 24 months Key difference vs other CBD products in the market - scientific formula supported by preclinical trials Company is looking to list on the CSE and up list in the US after a capital raise (currently on OTC Markets) Strong possibility for near term revenue, in advanced discussions with Licensed Processors and Distributors About CanaQuest Medical Corp: CanaQuest Medical Corp is a Life Science/Pharmaceutical Company developing health products utilizing cannabinoid molecules and other botanical compounds (pharmaceutical grade). The Company is the industry partner for research and product development with Dr. Steven Laviolette, a professor and neuroscientis...